Oropharynx (OPX) Biomarker Trial

Clinical trial NCT06356272 · RECRUITING

Trial details

NCT number: NCT06356272
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Metastatic Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Head and Neck Carcinoma Head and Neck Neoplasm Salivary Gland Neoplasms Thyroid Gland Neoplasm

Start date: 2019-11-15
Primary completion: 2029-11-30
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.